Xiaolong Kerri Yan

Title: Xiaolong Kerri Yan: Innovator in GLP-1R Agonist Compounds

Introduction

Xiaolong Kerri Yan is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of GLP-1R agonist compounds. His work has the potential to impact the treatment of metabolic diseases.

Latest Patents

Xiaolong Kerri Yan holds 1 patent for a GLP-1R agonist compound and its use. The patent details a compound represented by Formula I, or an isotope-labelled compound, a stereoisomer, or a pharmaceutically acceptable salt thereof. This compound exhibits excellent agonistic effects and pharmacodynamic properties on GLP-1R. As a modulator, it is useful for manufacturing a medicament aimed at the treatment, amelioration, or prevention of metabolic diseases and related conditions, showcasing broad application prospects.

Career Highlights

Throughout his career, Xiaolong Kerri Yan has worked with notable organizations, including Chongqing Pharmaceutical Research Institute Co., Ltd. and Yaopharma Co., Ltd. His experience in these companies has contributed to his expertise in pharmaceutical research and development.

Collaborations

Xiaolong Kerri Yan has collaborated with esteemed colleagues such as Wei Nie and Haoying Xu. These partnerships have further enhanced his research capabilities and innovation in the field.

Conclusion

Xiaolong Kerri Yan is a key figure in the development of GLP-1R agonist compounds, with a focus on addressing metabolic diseases. His contributions to medicinal chemistry are noteworthy and hold promise for future advancements in healthcare.